• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: STRYKER-ENDOSCOPY LAKELAND 5300; HYSTEROSCOPE (AND ACCESSORIES)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

STRYKER-ENDOSCOPY LAKELAND 5300; HYSTEROSCOPE (AND ACCESSORIES) Back to Search Results
Model Number MOR_10-401FC
Device Problem Use of Device Problem (1670)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 10/06/2023
Event Type  Injury  
Manufacturer Narrative
The device was returned to stryker sustainability solutions for evaluation.Upon inspection of the returned complaint device, the device handle appeared to be intact and showed no signs of visual anomalies.The drive cable housing assembly appears to be intact.No planarity damage to the outer shaft was observed.The returned complaint device was received with the cutting blade in the closed position.Visual inspection of the cutting window and blade revealed no presence of bioburden.The cutting blade appeared to be intact with no defects seen.The cutting blade functionality was tested manually by twisting the drive cable coil on the drive cable plug to open and close the blade.The blade functioned as intended for use.Manual continuity test was performed on the audio jack on the drive cable plug to verify continuity when the blade is closed and/or open.During testing of the blade opened, the device tested open.During testing of the blade closed, the device tested shorted.The device was then connected to the myosure controller unit to verify that the device blade would actuate when activated.The device was recognized by the controller and when activated the blade actuated in the cutting window opening and closing for 30 cycles.No abnormalities were observed during testing.The results of the visual and functional inspection determined that the reported event was not confirmed.A review of the dhr supports that the device met all inspection and test criteria prior to release from stryker.Therefore, the reported event could be attributed to: cable kinked or bent.Mishandling and excessive leverage on the device.Introduce bend or kink during set-up or usage.Ancillary equipment issues.The instructions for use (ifu) state: before using the myosure tissue removal system for the first time, please review all available product information.Use only the myosure control unit to connect to the reprocessed myosure tissue removal device.Use of any other drive mechanism may result in failure of the device to operate or lead to patient or physician injury.If visualization is lost at any point during a procedure, stop cutting immediately.Periodic irrigation of the tissue removal device tip is recommended to provide adequate cooling and to prevent accumulation of excised materials in the surgical site.Ensure that vacuum pressure >200 mm hg is available before commencing surgery before using the myosure tissue removal system, you should be experienced in hysteroscopic surgery with powered instruments.Healthy uterine tissue can be injured by improper use of the tissue removal device.Use every available means to avoid such injury.Do not use the reprocessed myosure tissue removal device to resect tissue that is adjacent to an implant.When resecting tissue in patients that have implants, assure that: the reprocessed myosure tissue removal device¿s cutting window is facing away from (i.E.180° opposite) the implant; the visual field is clear; and the reprocessed myosure tissue removal device¿s cutting window is engaged in tissue and is moved away from the implant as tissue resection proceeds.In the event an implant becomes entangled with a myosure cutter, the following steps are recommended: cease cutting immediately: kink the reprocessed myosure tissue removal device¿s outflow tube to prevent a loss of uterine distension; disconnect the reprocessed myosure tissue removal device¿s drive cable from the control box; grasp the end of the reprocessed myosure tissue removal device drive cable with a hemostat or other clamping device; hold the drive cable hub and tissue removal device to prevent twisting; open the tissue removal device¿s cutting window by manually twisting the hemostat counterclockwise; and gently pull the reprocessed myosure tissue removal device into the hysteroscope to detach the myosure device from the implant.Operation: 1.Push the power switch to the on (|) position.2.The foot pedal activates tissue removal device operation.The foot pedal turns the motor on and off.Once the foot pedal is depressed, the reprocessed tissue removal device accelerates and rotates to the set speed and continues until the foot pedal is released.3.Press the foot pedal and observe the reprocessed tissue removal device action to verify that the motor runs and that the cutting window is closed as shown in figure 5.4.Introduce the reprocessed tissue removal device through the straight 3 mm working channel of a hysteroscope.5.Under direct hysteroscopic visualization, position the reprocessed tissue removal device¿s side facing cutting window against target pathology.6.Press the foot pedal to activate the reprocessed tissue removal device¿s cutting blade.7.The reprocessed tissue removal device¿s reciprocating action alternately opens and closes the device¿s cutting window to the vacuum flow thereby drawing tissue into the cutting window.8.Cutting takes place when the reprocessed tissue removal device cutting edge rotates and translates across the reprocessed tissue removal device¿s cutting window.Caution: excessive leverage on the reprocessed tissue removal device does not improve cutting performance and, in extreme cases, may result in wear, degradation, and seizing of the cutter assembly.The reported event will continue to be monitored through post-market surveillance.
 
Event Description
It was reported the device was completed with dilation and curettage (d&c) because the complaint device activated and fired but then froze.There was no other patient injury or medical intervention reported and the extended procedure time reported was five minutes to replace the device.These are commonly used devices that are readily available.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
NA
Type of Device
HYSTEROSCOPE (AND ACCESSORIES)
Manufacturer (Section D)
STRYKER-ENDOSCOPY LAKELAND 5300
5300 region ct
lakeland FL 33815
Manufacturer (Section G)
STRYKER-ENDOSCOPY LAKELAND 5300
5300 region ct
lakeland FL 33815
Manufacturer Contact
andy dobos
1810 w. drake drive
tempe, AZ 85283
8888883433
MDR Report Key18086846
MDR Text Key327558885
Report Number0001056128-2023-00025
Device Sequence Number1
Product Code HIH
UDI-Device Identifier07613327507133
UDI-Public07613327507133
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K201756
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 11/07/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/07/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberMOR_10-401FC
Device Catalogue Number10-401FCRR
Device Lot Number14649676
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer10/18/2023
Is the Reporter a Health Professional? Yes
Date Manufacturer Received10/11/2023
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured02/20/2023
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? Yes
Type of Device Usage Reuse
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-